A role of thalidomide in reducing the presence of VEGF in a neoplasm was supported by previous research done in human neoplasms that demonstrated thalidomide reduced the production of VEGF by colonic [5], multiple myeloma [6], and prostatic neoplastic cells [7]. This evidence concerns the gene VEGFA and AL amyloidosis.